MeSH term
Frequency | Condition_Probility | Animals | 34 | 0.0 |
DNA Damage | 19 | 2.0 |
DNA Repair | 19 | 3.0 |
Gene Expression | 5 | 0.0 |
Humans | 85 | 0.0 |
DNA/analysis | 2 | 0.0 |
Dose-Response Relationship, Drug | 5 | 0.0 |
RNA, Messenger/metabolism | 5 | 0.0 |
Reverse Transcriptase Polymerase Chain Reaction | 8 | 0.0 |
Tumor Cells, Cultured | 6 | 0.0 |
Amino Acid Sequence | 13 | 0.0 |
DNA Repair/*physiology | 3 | 2.0 |
DNA-Formamidopyrimidine Glycosylase | 46 | 79.0 |
*Escherichia coli Proteins | 14 | 6.0 |
Molecular Sequence Data | 14 | 0.0 |
Mutagenesis | 2 | 0.0 |
N-Glycosyl Hydrolases/physiology | 2 | 40.0 |
Oxidative Stress | 9 | 2.0 |
Research Support, Non-U.S. Gov't | 56 | 0.0 |
Sequence Homology, Amino Acid | 7 | 0.0 |
Adenomatous Polyposis Coli/*genetics | 2 | 3.0 |
Adult | 9 | 0.0 |
Case-Control Studies | 8 | 0.0 |
Colorectal Neoplasms/*genetics | 2 | 0.0 |
DNA Glycosylases/*genetics | 4 | 57.0 |
Exons | 2 | 0.0 |
Female | 22 | 0.0 |
Genes, ras/genetics | 2 | 1.0 |
Loss of Heterozygosity | 4 | 0.0 |
Male | 20 | 0.0 |
Middle Aged | 14 | 0.0 |
Mutation | 12 | 0.0 |
Odds Ratio | 3 | 0.0 |
*Polymorphism, Genetic | 9 | 0.0 |
Hela Cells | 8 | 0.0 |
Protein Binding | 4 | 0.0 |
Protein Transport | 3 | 0.0 |
Substrate Specificity | 11 | 0.0 |
Cell Survival/radiation effects | 2 | 2.0 |
Comparative Study | 7 | 0.0 |
Hamsters | 2 | 0.0 |
Mice | 22 | 0.0 |
Aged | 9 | 0.0 |
Cell Line | 7 | 0.0 |
DNA/*metabolism | 2 | 0.0 |
Genotype | 10 | 0.0 |
Guanine/*analogs & derivatives/*metabolism | 10 | 71.0 |
Mice, Knockout | 5 | 0.0 |
Glutathione Transferase/*genetics | 2 | 0.0 |
N-Glycosyl Hydrolases/*genetics | 13 | 48.0 |
Polymerase Chain Reaction | 5 | 0.0 |
Polymorphism, Genetic | 4 | 0.0 |
Predictive Value of Tests | 2 | 0.0 |
Research Support, U.S. Gov't, P.H.S. | 25 | 0.0 |
*DNA Repair | 26 | 3.0 |
Kinetics | 6 | 0.0 |
Sensitivity and Specificity | 2 | 0.0 |
Adolescent | 2 | 0.0 |
*DNA Damage | 15 | 2.0 |
Diet | 2 | 0.0 |
Lung Neoplasms/etiology/*genetics | 2 | 7.0 |
*Oxidative Stress | 9 | 4.0 |
Polymorphism, Restriction Fragment Length | 2 | 0.0 |
Risk Factors | 6 | 0.0 |
Sequence Alignment | 5 | 0.0 |
Blotting, Western | 5 | 0.0 |
Dose-Response Relationship, Radiation | 4 | 1.0 |
Gamma Rays | 3 | 1.0 |
N-Glycosyl Hydrolases/*metabolism | 3 | 13.0 |
Time Factors | 5 | 0.0 |
DNA Mutational Analysis | 2 | 0.0 |
English Abstract | 3 | 0.0 |
N-Glycosyl Hydrolases/genetics | 3 | 42.0 |
DNA Glycosylases | 6 | 35.0 |
Escherichia coli/genetics | 4 | 0.0 |
Gene Expression Regulation, Enzymologic | 2 | 0.0 |
Genetic Complementation Test | 2 | 0.0 |
Guanine/*analogs & derivatives/metabolism | 5 | 20.0 |
N-Glycosyl Hydrolases/*genetics/metabolism | 4 | 66.0 |
Phenotype | 2 | 0.0 |
Sequence Analysis, DNA | 2 | 0.0 |
Tissue Distribution | 2 | 0.0 |
Guanosine/*analogs & derivatives/metabolism | 3 | 42.0 |
Cell Nucleus/*enzymology | 3 | 7.0 |
*DNA Glycosylases | 7 | 9.0 |
Mitochondria/*enzymology | 3 | 2.0 |
Oxidants/toxicity | 2 | 22.0 |
Oxidation-Reduction | 8 | 0.0 |
Point Mutation | 2 | 0.0 |
RNA, Messenger/genetics/metabolism | 2 | 0.0 |
*Saccharomyces cerevisiae Proteins | 2 | 0.0 |
Transfection | 6 | 0.0 |
DNA/metabolism | 5 | 0.0 |
DNA Replication | 4 | 1.0 |
DNA-(Apurinic or Apyrimidinic Site) Lyase | 6 | 9.0 |
Deoxyribonuclease (Pyrimidine Dimer) | 2 | 8.0 |
Deoxyribonuclease IV (Phage T4-Induced) | 4 | 8.0 |
Models, Genetic | 2 | 0.0 |
Transcription, Genetic | 6 | 0.0 |
Enzyme Induction | 2 | 0.0 |
Immunoglobulin G/immunology | 2 | 0.0 |
Liver/enzymology | 2 | 0.0 |
Rabbits | 2 | 0.0 |
Base Sequence | 19 | 0.0 |
Genetic Vectors/genetics | 2 | 0.0 |
N-Glycosyl Hydrolases/genetics/*physiology | 2 | 100.0 |
*Point Mutation | 2 | 0.0 |
Alleles | 3 | 0.0 |
Carbon-Oxygen Lyases/genetics | 2 | 28.0 |
DNA Repair/*genetics | 4 | 1.0 |
*DNA-(Apurinic or Apyrimidinic Site) Lyase | 2 | 5.0 |
*Mutation | 3 | 0.0 |
Gene Frequency | 3 | 0.0 |
In Vitro | 3 | 0.0 |
Isoenzymes/genetics/metabolism | 2 | 1.0 |
Mice, Inbred C57BL | 6 | 0.0 |
Alternative Splicing | 2 | 0.0 |
Escherichia coli/metabolism | 2 | 0.0 |
Chromatography, High Pressure Liquid | 2 | 0.0 |
Lung Neoplasms/*genetics | 4 | 1.0 |
*Polymorphism, Single Nucleotide | 2 | 0.0 |
*Loss of Heterozygosity | 2 | 0.0 |
DNA Glycosylases/genetics/metabolism | 3 | 75.0 |
Deoxyguanosine/*analogs & derivatives/metabolism | 2 | 18.0 |
Genetic Predisposition to Disease | 4 | 0.0 |
Nucleic Acids/*metabolism | 2 | 66.0 |
Reactive Oxygen Species/*metabolism | 2 | 1.0 |
DNA, Mitochondrial/*genetics | 3 | 2.0 |
Gene Silencing | 2 | 0.0 |
Recombinant Fusion Proteins/genetics/metabolism | 2 | 0.0 |
Rats | 5 | 0.0 |
Research Support, U.S. Gov't, Non-P.H.S. | 3 | 0.0 |
Cells, Cultured | 2 | 0.0 |
DNA Glycosylases/*metabolism | 6 | 75.0 |
DNA Ligases/metabolism | 2 | 6.0 |
DNA-(Apurinic or Apyrimidinic Site) Lyase/*metabolism | 2 | 100.0 |
Saccharomyces cerevisiae | 2 | 0.0 |
DNA Primers | 6 | 0.0 |
Saccharomyces cerevisiae/enzymology | 2 | 3.0 |
Guanine/analogs & derivatives/metabolism | 3 | 20.0 |
DNA/genetics | 2 | 0.0 |
Deoxyguanosine/*analogs & derivatives/genetics | 2 | 100.0 |
N-Glycosyl Hydrolases/genetics/metabolism | 2 | 66.0 |
Up-Regulation | 3 | 0.0 |
DNA Glycosylases/metabolism | 2 | 50.0 |
*Genetic Predisposition to Disease | 2 | 0.0 |
Bromates/toxicity | 2 | 66.0 |
Chromosome Mapping | 2 | 0.0 |
RNA, Messenger/genetics | 2 | 0.0 |
DNA, Complementary | 3 | 0.0 |
Signal Transduction | 2 | 0.0 |
Mammals | 2 | 0.0 |
Saccharomyces cerevisiae/genetics | 2 | 0.0 |
Lung Neoplasms/*genetics/pathology | 2 | 2.0 |
Cloning, Molecular | 2 | 0.0 |
Saccharomyces cerevisiae/enzymology/*genetics | 2 | 7.0 |
Cell Line, Tumor | 4 | 0.0 |
Oligonucleotides/chemistry | 2 | 1.0 |
Oxygen/*metabolism | 2 | 1.0 |
Reactive Oxygen Species/metabolism | 2 | 0.0 |
DNA/*chemistry | 3 | 5.0 |
Cell Survival | 2 | 0.0 |
*DNA-Binding Proteins | 3 | 0.0 |
*Endonucleases | 3 | 3.0 |
Mice, Inbred BALB C | 2 | 0.0 |
Cell Division | 2 | 0.0 |
Genetics, Population | 2 | 0.0 |
Japan | 2 | 0.0 |
Gene Deletion | 2 | 0.0 |
Polymorphism, Genetic/*genetics | 2 | 0.0 |
RNA, Messenger/biosynthesis | 3 | 0.0 |
*Genes, Tumor Suppressor | 2 | 0.0 |
Microsatellite Repeats | 2 | 0.0 |
Prognosis | 2 | 0.0 |
Escherichia coli/enzymology/genetics | 2 | 3.0 |
*Germ-Line Mutation | 2 | 0.0 |
Cell Line, Transformed | 2 | 0.0 |
DNA/chemistry/metabolism | 2 | 2.0 |
N-Glycosyl Hydrolases/metabolism | 2 | 11.0 |
